Enlivex Ltd.
ENLV
$2.06
▲
+0.09
(+4.57%)
at close
15
Visible periods
5
Metrics
Peer-ranked
Benchmarks
Price Chart
58
Health
Fair
Bullish
auto_awesome
Analytical Summary
Enlivex Ltd. shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.
Market Cap
—
Dividend Yield
—
Revenue Growth
—
Op. Margin
—
ROIC
—
FCF / Share
—
Trailing P/E
—
Price / Book
0.3x
FCF Yield
—
Debt / Equity
—
info
Valuation on last close. End-of-day price, Aug 7, 2026.
trending_up
Bullish Indicators
- Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning
Bearish Risks
- No bearish risks detected.
Health Breakdown
Returns
98
Financial Health ↑
28
Cash Quality
22
Financial view
Statement lens
Choose the reporting cadence, isolate a period range, or search directly for a metric.
Is the balance sheet risky?
1 metrics
| Metric | Q4 FY2025 Dec 31, 2025 20-F ↗ | Q4 FY2024 Dec 31, 2024 20-F ↗ | Q4 FY2023 Dec 31, 2023 20-F ↗ | Q4 FY2022 Dec 31, 2022 20-F ↗ | Q4 FY2021 Dec 31, 2021 20-F ↗ | Q4 FY2020 Dec 31, 2020 20-F ↗ | Q4 FY2019 Dec 31, 2019 20-F ↗ | Q4 FY2018 Dec 31, 2018 20-F ↗ | Q4 FY2017 Dec 31, 2017 20-F ↗ | Q4 FY2016 Dec 31, 2016 20-F ↗ | Q4 FY2015 Dec 31, 2015 20-F ↗ | Q4 FY2014 Dec 31, 2014 20-F ↗ | Q4 FY2013 Dec 31, 2013 20-F ↗ | Q4 FY2012 Dec 31, 2012 20-F ↗ | Q4 FY2011 Jan 22, 2012 20-F ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Debt (USD) | $-1.89M | $-3.30M | $-813.00K | $-49.95M | $-11.20M | $-5.67M | $-3.95M | $-9.74M | $-9.01M | $-6.87M | $-7.29M | $-10.58M | $-270.00K | $-146.00K | $0.00 |
How resilient is the balance sheet?
2 metrics
| Metric | Q4 FY2025 Dec 31, 2025 20-F ↗ | Q4 FY2024 Dec 31, 2024 20-F ↗ | Q4 FY2023 Dec 31, 2023 20-F ↗ | Q4 FY2022 Dec 31, 2022 20-F ↗ | Q4 FY2021 Dec 31, 2021 20-F ↗ | Q4 FY2020 Dec 31, 2020 20-F ↗ | Q4 FY2019 Dec 31, 2019 20-F ↗ | Q4 FY2018 Dec 31, 2018 20-F ↗ | Q4 FY2017 Dec 31, 2017 20-F ↗ | Q4 FY2016 Dec 31, 2016 20-F ↗ | Q4 FY2015 Dec 31, 2015 20-F ↗ | Q4 FY2014 Dec 31, 2014 20-F ↗ | Q4 FY2013 Dec 31, 2013 20-F ↗ | Q4 FY2012 Dec 31, 2012 20-F ↗ | Q4 FY2011 Jan 22, 2012 20-F ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Working Capital (USD) | $1.73B | $22.19M | $27.70M | $45.72M | $81.72M | $33.75M | $10.44M | $9.15M | $8.42M | $8.61M | $17.88M | $30.61M | $168.00K | — | — |
| Total Equity (USD) | $1.93B | $23.59M | $30.08M | $56.84M | $85.04M | $35.49M | $11.28M | $9.71M | $8.49M | $8.70M | $17.93M | $30.67M | $175.00K | $75.00K | $0.00 |
⌨️ Keyboard Shortcuts
/ Search
Esc Clear
A Annual
Q Quarterly
1-7 Jump to category
R Reset
Secondary lens
Benchmark Lens
Compare ENLV against peers after checking the statement evidence.
Open lens
Benchmark Lens
Compare ENLV against peers after checking the statement evidence.
Signals
Key bullish and bearish indicators for ENLV
Bullish
1
Return on Common Equity (%)
63.9%
Return on Common Equity (%) is in the top quartile
Bearish
0
No bearish signals detected
Percentile Rankings
How ENLV compares to all companies
Return on Common Equity (%)
63.9%
Top 5%
Peers: Top 3%
Peer Comparison
ENLV vs similar peers
Return on Common Equity (%)
ENLV
63.9%
#9 of 356
OTLC
94.9%
RIGL
93.8%
ETST
84.5%
Peer median: -46.86
Profit Margin (%)
ENLV
—
#None of 116
TBPH
98.5%
HCM
83.3%
ZVRA
78.2%
Peer median: -0.34
Debt to Equity
ENLV
—
#None of 93
BIOA
0.00x
ABUS
0.00x
SPRB
0.00x
Peer median: 0.25
Operating Margin (%)
ENLV
—
#None of 112
RPRX
65.6%
PTCT
50.1%
CRMD
48.2%
Peer median: -1.35
Compare ENLV with peers
Stack ENLV against similar companies across every metric on this page.
north_east Open comparisonbar_chart Data from SEC EDGAR XBRL filings
Synced 1 week ago 15 years · 15 quarters